pep-05030 v1 CC-BY-SA-4.0
Somatoliberin blood-sugar & appetite peptide
A lab-stage peptide designed to switch on the body's GLP-1 pathway, the same system that helps control blood sugar and curb hunger. Not an approved medicine.
status
Someone proposed this peptide.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
A computer predicted how the peptide binds to its target.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
Someone else ran the same prediction and got the same result.
A second contributor repeated the computation on their own hardware and the scores matched.
The peptide was actually made in a lab.
A chemistry service or a researcher ordered the sequence, it was manufactured, and mass spectrometry confirmed the right molecule was produced.
The peptide was tested on its target in a lab.
A binding or activity measurement confirmed that it actually does what the computer predicted — or didn't.
prediction metrics
ipTM0.862
pTM0.829
avg pLDDT71.0
ranking score0.741
STRUCTURE · PEP-05030 × GLP-1R
ranking0.741
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence
151015202530354042
HVDAIFTTNYRKLL SQLYARKVIQDIMN KQGERIQEQRARLS
in the news
details
▸full evidence table2 metrics
| metric | value | tool |
|---|---|---|
| ipTM | 0.8620134592056274 | boltz-2 |
| ranking score | 0.7405052185058594 | boltz-2 |
▸structural qualityopenfold3
| metric | value | note |
|---|---|---|
| gpde | 0.826 | global PDE — lower = better |
| disorder | NaN | fraction disordered |
▸3-letter notation
His-Val-Asp-Ala-Ile-Phe-Thr-Thr-Asn-Tyr-Arg-Lys-Leu-Leu-Ser-Gln-Leu-Tyr-Ala-Arg-Lys-Val-Ile-Gln-Asp-Ile-Met-Asn-Lys-Gln-Gly-Glu-Arg-Ile-Gln-Glu-Gln-Arg-Ala-Arg-Leu-Ser
▸recipeboltz-2 1.0
| parameter | value |
|---|---|
| model | boltz-2 1.0 |
| weights | — |
| hardware | nvidia_nim_api |
| mlx version | — |
| python | — |
| random seed | — |
| msa strategy | none |
| diffusion samples | 1 |
| runtime | — |
| predicted by | mlx@peptide |
| predicted at | 2026-04-24 |
▸citationbibtex
peptidemodel (2026). Somatoliberin blood-sugar & appetite peptide (pep-05030, v1). PeptideModel. https://peptidemodel.com/card/pep-05030
@peptide{pep05030,
sequence = {HVDAIFTTNYRKLLSQLYARKVIQDIMNKQGERIQEQRARLS},
target = {glp-1r},
author = {peptidemodel},
year = {2026},
status = {computed}
} related peptides
references
discussion
sign in to comment